Whether your product is a small molecule or a biotech pharmaceutical—protein, peptide or oligonucleotide—we can assist you in the design and execution of pre-formulation and formulation development studies to define your final formulation. The results of formulation development work will be integrated with primary packaging selection and process design phases, to meet or exceed your performance expectations for a clinically sound, marketable parenteral drug product.
If you choose to lyophilize your drug product, we have the experience and tools to design a stable dosage form, along with an effective and efficient lyophilization cycle. Our scientists apply extensive knowledge of successful formulation strategies for stabilizing sensitive protein and peptide pharmaceuticals. With a differential scanning calorimeter and lab-scale lyophilizers, we can expertly establish optimum lyophilization cycle parameters for your drug product.
- Liquid formulations
-
Lyophilized formulations
-
Suspension and dispersed-system dosage forms
-
Manufacturing process design and optimization of existing processes
-
Manufacturing scale-up and technology transfer